| 摘要: |
| ［摘要］ 心房颤动(AF)在人群中的患病率正在不断增加,成为新世纪心血管疾病中一大新的流行疾病。迄今为止,在AF的有效治疗上仍存在着很多问题,尤其是如何在高危人群中采取措施预防它的发生及复律后窦性心律维持可谓基本空白。近年来许多研究发现, 血管紧张素Ⅱ与AF的发生和维持有密切关系，血管紧张素Ⅱ受体拮抗剂(ARA)具有减少AF的作用。该文从发病机理、临床治疗等方面阐述ARA对AF的作用。 |
| 关键词: 血管紧张素Ⅱ受体拮抗剂 心房颤动 研究进展 |
| DOI：10.3969/j.issn.1674-3806.2010.04.41 |
| 分类号:R 541.7 |
| 基金项目: |
|
| Clinical research progress of angiotensin II receptor antagonist in the treatment of atrial fibrillation |
|
QI Chuan-xing, PANG Ming-mei
|
|
Department of Internal Medicine,Gaomi Economic Development Zone Hospital,Shandong 261500,China
|
| Abstract: |
| ［Abstract］ The atrial fibrillation(AF),whose prevalence rate in the population is growing, becomes popular disease in cardiovascular disease in the new century. Until now, in the effective treatment of AF,there are still many problems to be solved, particularly the problem about how to take measures to prevent its occurrence and maintain sinus rhythm after cardioversion in high-risk populations can be described as basically a blank.In recent years, many studies have found that angiotensin Ⅱ is closely related to the occurrence and maintenance of AF, angiotensin Ⅱreceptor antagonist(ARA) has the role of reducing AF.In this paper,from aspects of pathogenesis, clinical treatment and so on elaborates the role of ARA on the AF. |
| Key words: Angiotensin II receptor antagonist (ARA) Atrial fibrillation Clinical research |
